Dean Investment Associates’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-118,805
Closed -$1.09M 234
2020
Q1
$1.09M Buy
+118,805
New +$717K 0.23% 151
2017
Q4
Sell
-127,380
Closed -$3.72M 219
2017
Q3
$3.72M Sell
127,380
-78,705
-38% -$2.32M 0.57% 75
2017
Q2
$6.63M Buy
206,085
+80,915
+65% +$2.66M 1.01% 17
2017
Q1
$4.33M Buy
+125,170
New +$4.47M 0.72% 61
2016
Q4
Sell
-109,490
Closed -$3.8M 214
2016
Q3
$3.8M Buy
109,490
+2,770
+3% +$97K 0.71% 66
2016
Q2
$3.99M Buy
+106,720
New +$4.01M 0.78% 59
2015
Q4
Sell
-84,945
Closed -$2.71M 223
2015
Q3
$2.71M Buy
+84,945
New +$2.89M 0.61% 79

Other funds holding ACH

Dean Investment Associates's ACH Position: Q2 2020 in Review

Dean Investment Associates sold out of Accendra Health (ACH) in Q2 2020, closing a stake of 118,805 shares — an estimated $1.09M sold.

Dean Investment Associates first reported a position in ACH in Q3 2015 and held it in 7 quarters. The position peaked at $6.63M in Q2 2017. 188 funds tracked by Wall St. Rank hold ACH as of Q2 2020.

  • Dean Investment Associates reported no remaining Accendra Health position as of Q2 2020 after selling out during the quarter.
  • Dean Investment Associates sold 118,805 Accendra Health shares in Q2 2020, an estimated $1.09M.
  • Dean Investment Associates first reported a position in Accendra Health in Q3 2015 and held it in 7 quarters.
  • Dean Investment Associates's Accendra Health position peaked at $6.63M in Q2 2017.
  • 188 funds tracked by Wall St. Rank held Accendra Health as of Q2 2020.

Based on Dean Investment Associates's 13F filing for Q2 2020, filed 14 Aug 2020.